Investors of Park Ha Biological Technology Join Class Action Against BYAH
Overview
Recent events surrounding Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) have drawn attention from investors and legal experts alike. Robbins LLP has announced a securities class action that impacts all individuals and entities that acquired Park Ha securities between December 27, 2024, and July 8, 2025. The firm is reaching out to potential investors who may wish to lead this class action and offers further information regarding their rights and options.
Allegations Against Park Ha
The class action centers on allegations that Park Ha engaged in market manipulation through an elaborate scheme. This operation predominantly relied on misinformation disseminated via social media and involved individuals impersonating financial professionals to mislead investors. These manipulative practices caused substantial misleading of investors, ultimately affecting the company’s stock performance and value.
According to the filed complaint:
- - Park Ha allegedly didn't adequately disclose risks linked to suspected market manipulation and fraudulent promotional activities.
- - The claims indicate that the company orchestrated a